FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10

5-Fluorouracil (5-FU) is the most commonly used chemotherapeutic agent for colorectal cancer (CRC). However, frequently occurred 5-FU resistance poses a great challenge in the clinic. Elucidating the underlying mechanisms and developing effective strategies against 5-FU resistance are highly desired...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Tao, Geng, Jian, Wang, Ye, Wang, Liya, Huang, Mengxi, Chen, Jing, Zhang, Kai, Xue, Lijun, Liu, Xiaobei, Mao, Xiaobei, Chen, Yanan, Wang, Qian, Dai, Tingting, Ren, Lili, Yu, Hongju, Wang, Rui, Chen, Longbang, Chen, Cheng, Chu, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352423/
https://www.ncbi.nlm.nih.gov/pubmed/28051999
http://dx.doi.org/10.18632/oncotarget.14351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352423/
https://www.ncbi.nlm.nih.gov/pubmed/28051999
http://dx.doi.org/10.18632/oncotarget.14351

Ejemplares similares